Approval · Notice of Compliance 9013 · 2007
ISOFLURANE: Notice of Compliance 9013
Issued September 7, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9013
- Date
- September 7, 2007
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update and other revisions to the product monograph
- Therapeutic class
- Inhalation anesthetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ISOFLURANE | Not yet assigned | — |
Medicinal ingredients
- ISOFLURANE 99.9 PER